📰 Michael Corbo News
Michael Corbo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Corbo. Real-time updates on events, politics, business and more.
February 7, 2023
News - Radu Palamariu (Alcott Global) and Knut Alicke (McKinsey & Company), supply chain thought leaders and bestselling authors are excited to announce the
February 7, 2023
Listeners get insightful stories from 26 leading supply chain executives, CEOs, and thought leaders plus access to the CHAIN Model for Supply Chain Leadership
December 21, 2022
The FDA has accepted for review the NDA for etrasimod for the treatment of patients with moderately to severely active ulcerative colitis (UC).
September 9, 2022
The FDA has accepted for filing the NDA for ritlecitinib for patients 12 years of age and older with alopecia areata.
April 6, 2022
Positive results for etrasimod could give Pfizer a quick win with its acquisition of Arena.
April 1, 2022
Phase III study results show ulcerative colitis patients treated with etrasimod achieved statistically significant improvements in clinical remission.
March 30, 2022
Pfizer reported results from a second phase 3 trial of etrasimod to treat patients with moderately to severely active ulcerative colitis ((UC))
October 15, 2021
Pfizer Inc. (NYSE: PFE) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a
October 15, 2021
CHMP also recommends XELJANZ (tofacitinib) approval for the treatment of adults with active ankylosing spondylitis Pfizer Inc. (NYSE: PFE) today announced that the European Medicines Agency's